Getting to 90-90-90 in paediatric HIV: What is needed?
Mary-Ann
MA
Davies
Jorge
J
Pinto
Marlène
M
Bras
90-90-90 target; AIDS; ART; HIV; HIV comorbidities; HIV drug resistance; HIV prevention; HIV/AIDS; PITC; SMS; adherence; adolescents; antiretroviral adherence; antiretroviral therapy; antiretroviral treatment; antiretrovirals; child survival; children; development; diagnosis; double dividend; epidemiology; formulations; guidelines; infant; integration; low birth weight; low- and middle-income countries; management; maternal-child health; non-nucleoside reverse transcriptase inhibitor; optimization; paediatric HIV; perinatal HIV infection; point of care; premature; prevention of mother-to-child HIV transmission; protease inhibitor; psychological complications; small for gestation; social protection; transition; treatment; tuberculosis